Text Size

Evaluation of an Individualised Written Education Package for Stroke Patients

This study has been completed.
Sponsor:
Information provided by:
Medical Benefits Fund of Australia
ClinicalTrials.gov Identifier:
NCT00126295
First received: August 2, 2005
Last updated: August 18, 2005
Last verified: August 2005
History of Changes
  Purpose

The primary aim of the randomised controlled trial was to evaluate the effectiveness of a tailored written education package (“What you need to know about stroke") on the outcomes of:

  • Knowledge about stroke, self-efficacy, anxiety, depression, perceived health status, satisfaction with the content and presentation of the information received, and desire for additional information for patients following stroke and
  • Knowledge about stroke, self-efficacy, anxiety, depression, satisfaction with the content and presentation of the information received, and desire for additional information for their carers.

A secondary aim was to evaluate the effect of written information on the outcomes of knowledge about stroke, self-efficacy, anxiety, depression, and perceived health status of patients following stroke and on knowledge about stroke, self-efficacy, anxiety, and depression of their carers.


Condition Intervention Phase
Stroke
 Device: 'What you need to know about stroke' education package
 Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Double-Blind
Primary Purpose: Educational/Counseling/Training
Official Title: Evaluation of a Computer-Generated Individualised Written Education Package for Patients Following Stroke and Their Carers

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Medical Benefits Fund of Australia:

Primary Outcome Measures:
  • knowledge about stroke
  • self-efficacy
  • anxiety
  • depression
  • perceived health status (patients only)
  • satisfaction with the content and presentation of the information received
  • desire for additional information

Estimated Enrollment: 130
Study Start Date: June 2003
Estimated Study Completion Date: May 2005
  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Had a stroke or transient ischemic attack (TIA) or was the informal carer of a person who had a stroke or TIA;
  • Had a reported English-proficiency level, corrected hearing and vision, and communication status adequate to participate in an interview and complete assessment tasks;
  • Did not have reported or observable dementia;
  • Lived within 50km of the hospital, for ease of follow-up; and
  • Was medically stable.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00126295

Locations
Australia, Queensland
Royal Brisbane Hospital
Brisbane, Queensland, Australia, 4029
Sponsors and Collaborators
Medical Benefits Fund of Australia
Investigators
Principal Investigator: Tammy C Hoffmann The University of Queensland
Principal Investigator: Kryss McKenna The University of Queensland
Principal Investigator: Linda Worrall The University of Queensland
Principal Investigator: Stephen Read Royal Brisbane Hospital
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00126295     History of Changes
Other Study ID Numbers: 2002000023
Study First Received: August 2, 2005
Last Updated: August 18, 2005
Health Authority: Australia: Human Research Ethics Committee

Additional relevant MeSH terms:
Stroke
Cerebral Infarction
Cerebrovascular Disorders
Brain Diseases
Central Nervous System Diseases
 Nervous System Diseases
Vascular Diseases
Cardiovascular Diseases
Brain Infarction
Brain Ischemia

ClinicalTrials.gov processed this record on June 18, 2013